EntryPoint Capital’s Tarsus Pharmaceuticals TARS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,302
Closed -$47.3K 1598
2024
Q1
$47.3K Sell
1,302
-2,082
-62% -$75.7K 0.04% 794
2023
Q4
$68.5K Buy
+3,384
New +$68.5K 0.07% 572